Flowcytometric quantitation of hepatitis B viral antigens in hepatocytes from regular and fine-needle biopsies

Journal of Virological Methods

Volumn 142, Issue 1-2, 2007, Pages 189-197

  van der Laan, Luc J W ^a   Taimr, Pavel ^a   Kok, Alice ^a   Sprengers, Dave ^a   Zondervan, Pieter E ^a   Tilanus, Hugo W ^a   Janssen, Harry L A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aspiration biopsy; Flow cytometry; FNAB; HBcAg; HBsAg; HBV; Intrahepatic

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; PEGINTERFERON ALPHA2A; VIRUS ANTIGEN; VIRUS DNA;

ADULT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; MALE; NEEDLE BIOPSY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; BIOPSY; BIOPSY, FINE-NEEDLE; FEMALE; FLOW CYTOMETRY; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; LIVER; MALE; MIDDLE AGED; VIROLOGY;

HEPATITIS B VIRUS;

EID: 34247093278     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.01.027     Document Type: Article

References (32)

1. Alberti A. Can serum HBV-DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B?. Hepatology 38 (2003) 18-20
2. Ballare M., Lavarini C., Brunetto M.R., Petruzzelli E., Dovis M., Molino G., and Bonino F. Relationship between the intrahepatic expression of 'e' and 'c' epitopes of the nucleocapsid protein of hepatitis B virus and viraemia. Clin. Exp. Immunol. 75 (1989) 64-69
3. Bianchi L., and Gudat F. Immunopathology of hepatitis B. Prog. Liver Dis. 6 (1979) 371-392
4. Chu C.M., and Liaw Y.F. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis. Gastroenterology 92 (1987) 220-225
5. Franca A.V., Valerio H.M., Trevisan M., Escanhoela C., Seva-Pereira T., Zucoloto S., Martinelli A., and Soares E.C. Fine needle aspiration biopsy for improving the diagnostic accuracy of cut needle biopsy of focal liver lesions. Acta Cytol. 47 (2003) 332-336
6. Galle P.R., Hagelstein J., Kommerell B., Volkmann M., Schranz P., and Zentgraf H. In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology 106 (1994) 664-673
7. Hadziyannis S.J., Lieberman H.M., Karvountzis G.G., and Shafritz D.A. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg vs. anti-HBe positive carriers of hepatitis B virus. Hepatology 3 (1983) 656-662
8. Hayry P., and Lautenschlager I. Fine-needle aspiration biopsy in transplantation pathology. Semin. Diagn. Pathol. 9 (1992) 232-237
9. Hayry P., von Willebrand E., Ahonen J., Eklund B., and Lautenschlager I. Monitoring of organ allograft rejection by transplant aspiration cytology. Ann. Clin. Res. 13 (1981) 264-287
10. Iloeje U.H., Yang H.I., Su J., Jen C.L., You S.L., and Chen C.J. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 130 (2006) 678-686
11. Ito K., Tanaka Y., Orito E., Hirashima N., Ide T., Hino T., Kumashiro R., Kato A., Nukaya H., Sakakibara K., Mukaide M., Ito H., Sata M., Ueda R., and Mizokami M. Predicting relapse after cessation of Lamivudine monotherapy for chronic hepatitis B virus infection. Clin. Infect. Dis. 38 (2004) 490-495
12. Jazayeri M.S., Dornan E.S., Boner W., Fattovich G., Hadziyannis S., and Carman W.F. Intracellular distribution of hepatitis B virus core protein expressed in vitro depends on the sequence of the isolate and the serologic pattern. J. Infect. Dis. 189 (2004) 1634-1645
13. Kuijf M.L., Kwekkeboom J., Kuijpers M.A., Willems M., Zondervan P.E., Niesters H.G., Hop W.C., Hack C.E., Paavonen T., Hockerstedt K., Tilanus H.W., Lautenschlager I., and Metselaar H.J. Granzyme expression in fine-needle aspirates from liver allografts is increased during acute rejection. Liver Transpl. 8 (2002) 952-956
14. Kwekkeboom J., Zondervan P.E., Kuijpers M.A., Tilanus H.W., and Metselaar H.J. Fine-needle aspiration cytology in the diagnosis of acute rejection after liver transplantation. Br. J. Surg. 90 (2003) 246-247
15. Lautenschlager I., Hockerstedt K., and Hayry P. Fine-needle aspiration biopsy in the monitoring of liver allografts. Transpl. Int. 4 (1991) 54-61
16. Lautenschlager I., Hockerstedt K., Salmela K., Isoniemi H., Holmberg C., Jalanko H., and Hayry P. Fine-needle aspiration biopsy in the monitoring of liver allografts. Different cellular findings during rejection and cytomegalovirus infection. Transplantation 50 (1990) 798-803
17. Lautenschlager I., Hockerstedt K., Taskinen E., Korsback C., Makisalo H., and Hayry P. Fine-needle aspiration biopsy in the monitoring of liver allografts: I. Correlation between aspiration biopsy and core biopsy in experimental pig liver allografts. Transplantation 46 (1988) 41-46
18. Lindor K.D., Bru C., Jorgensen R.A., Rakela J., Bordas J.M., Gross J.B., Rodes J., McGill D.B., Reading C.C., James E.M., Charboneau J.W., Ludwig J., Batts K.P., and Zinsmeister A.R. The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology 23 (1996) 1079-1083
19. McMahon B.J. Epidemiology and natural history of hepatitis B. Semin. Liver Dis. 25 Suppl. 1 (2005) 3-8
20. Perrault J., McGill D.B., Ott B.J., and Taylor W.F. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology 74 (1978) 103-106
21. Pitman M.B. Fine needle aspiration biopsy of the liver. Principal diagnostic challenges. Clin. Lab. Med. 18 (1998) 483-506
22. Reuben A. Just a second. Hepatology 38 (2003) 1316-1320
23. Sells M.A., Zelent A.Z., Shvartsman M., and Acs G. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J. Virol. 62 (1988) 2836-2844
24. Sprengers D., van der Molen R.G., Kusters J.G., Kwekkeboom J., van der Laan L.J., Niesters H.G., Kuipers E.J., De Man R.A., Schalm S.W., and Janssen H.L. Flow cytometry of fine-needle-aspiration biopsies: a new method to monitor the intrahepatic immunological environment in chronic viral hepatitis. J. Viral Hepat. 12 (2005) 507-512
25. Sung J.J., Wong M.L., Bowden S., Liew C.T., Hui A.Y., Wong V.W., Leung N.W., Locarnini S., and Chan H.L. Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy. Gastroenterology 128 (2005) 1890-1897
26. Tang T.J., de Man R.A., Kusters J.G., Kwekkeboom J., Hop W.C., van der Molen R.G., Schalm S.W., and Janssen H.L. Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients. J. Med. Virol. 72 (2004) 215-222
27. Terjung B., Lemnitzer I., Dumoulin F.L., Effenberger W., Brackmann H.H., Sauerbruch T., and Spengler U. Bleeding complications after percutaneous liver biopsy. An analysis of risk factors. Digestion 67 (2003) 138-145
28. Thampanitchawong P., and Piratvisuth T. Liver biopsy: complications and risk factors. World J. Gastroenterol. 5 (1999) 301-304
29. Umeda M., Marusawa H., Seno H., Katsurada A., Nabeshima M., Egawa H., Uemoto S., Inomata Y., Tanaka K., and Chiba T. Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers. J. Hepatol. 42 (2005) 806-812
30. van der Eijk A.A., Niesters H.G., Hansen B.E., Heijtink R.A., Janssen H.L.A., Schalm S.W., and de Man R.A. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha. J. Viral Hepat. 13 (2006) 96-103
31. Werle-Lapostolle B., Bowden S., Locarnini S., Wursthorn K., Petersen J., Lau G., Trepo C., Marcellin P., Goodman Z., Delaney W.E.t., Xiong S., Brosgart C.L., Chen S.S., Gibbs C.S., and Zoulim F. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126 (2004) 1750-1758
32. Zoulim F. Assessment of treatment efficacy in HBV infection and disease. J. Hepatol. 44 (2006) S95-S99